Brief: Freeline Announces FDA Clearance Of IND Application For FLT201 For Gaucher Disease Type 1

Freeline Therapeutics Holdings

06/01/2022 12:19

Jan 6 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
APPLICATION FOR FLT201 FOR GAUCHER DISEASE TYPE 1
    * FREELINE THERAPEUTICS HOLDINGS PLC - FLT201 PHASE 1/2
TRIAL FOR
GAUCHER DISEASE TYPE 1 ON TRACK FOR PATIENT DOSING IN FIRST HALF
OF 2022

Source text for Eikon:  ID:nGNX2h6VgF 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))